Mediterr J Hematol Infect Dis. 2015 Feb 15;7(1):e2015019. doi: 10.4084/MJHID.2015.019. eCollection 2015.

Study of serum haptoglobin level and its relation to erythropoietic activity in Beta thalassemia children.

Mediterranean journal of hematology and infectious diseases

Seham M Ragab, Manal A Safan, Eman A Badr

PMID: 25745546 PMCID: PMC4344174 DOI: 10.4084/MJHID.2015.019

Abstract

BACKGROUND: Serum haptoglobin (Hp) is a reliable marker for hemolysis regardless the inflammatory state.

OBJECTIVE: We investigated the possible relation between Hp depletion and hemolysis severity, hepatitis C virus (HCV) infection and iron load in β-thalassemia children.

METHODS: Twenty two β-thalassemia major (TM),20 β-thalassemia intermedia (TI) children with 20 age and sex matched healthy controls were involved. Pre-transfusion hemoglobin level was considered. Serum ferritin, Hp and transferrin receptor levels (sTfR) (by ELISA ), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (by colorimetric method) were assayed. Markers of hepatitis C virus (HCV) were done by PCR.

RESULTS: The mean Hp levels among the studied groups were as follows; 8.02 ± 0.93 (mg/dl), 8.6 ±0.72 (mg/dl) and 122 ± 18.5(mg/dl) for TM, TI and the controls respectively. Both patient groups had significantly lower Hp level compared to the controls (P<0.0001) with significant lower level in TM compared to TI children ( P= 0.034). Significant inverse correlations were found between serum Hp and sTfR levels ( reflecting the erythropoietic activity) in thalassemia children combined and in each group (TM and TI) as well as among HCV infected children. STfR was the only significant independent predictor for serum Hp level (t= -5.585, P<0.0001). Among HCV infected patients, no significant correlation was found between serum Hp and serum transaminases.

CONCLUSION: Serum Hp depletion in thalassemia had significant relation to disease severity and correlated well with their erythropoietic activity, as assessed by the measurement of sTfR without significant relation to HCV infection. Extensive multicenter studies are recommended.

References

1. Haematologica. 2007 May;92(5):583-8 - PubMed
2. Transfusion. 1997 Feb;37(2):135-40 - PubMed
3. J Trop Pediatr. 2004 Dec;50(6):369-71 - PubMed
4. Singapore Med J. 2006 Feb;47(2):138-42 - PubMed
5. Semin Hematol. 2001 Oct;38(4):360-6 - PubMed
6. EMBO J. 1987 Jul;6(7):1905-12 - PubMed
7. Br J Haematol. 2008 Apr;141(1):100-4 - PubMed
8. Eur J Clin Invest. 2006 Mar;36(3):202-9 - PubMed
9. Ann Hepatol. 2013 Jan-Feb;12 (1):54-61 - PubMed
10. J Biol Chem. 1990 Nov 5;265(31):19077-81 - PubMed
11. Blood. 2008 Aug 1;112(3):875-85 - PubMed
12. Nature. 2001 Jan 11;409(6817):198-201 - PubMed
13. Gastroenterol Clin Biol. 1993;17(5):364-9 - PubMed
14. Indian J Hematol Blood Transfus. 2011 Jun;27(2):65-9 - PubMed
15. J Lab Clin Med. 1992 Apr;119(4):385-90 - PubMed
16. Haematologica. 2003 Jun;88(6):631-6 - PubMed
17. Inflamm Res. 2012 Oct;61(10):1101-6 - PubMed
18. Trans R Soc Trop Med Hyg. 2008 Aug;102(8):735-42 - PubMed
19. Am J Hematol. 2014 Apr;89(4):443-7 - PubMed
20. Blood. 1998 Mar 15;91(6):2139-45 - PubMed
21. Curr Top Hematol. 1978;1:151-92 - PubMed
22. Adv Hum Genet. 1982;12:189-261, 453-4 - PubMed
23. Curr Opin Hematol. 2002 Mar;9(2):123-6 - PubMed
24. Clin Chem. 1997 Oct;43(10):2012-3 - PubMed
25. Pediatr Clin North Am. 2002 Dec;49(6):1165-91, v - PubMed
26. Adv Exp Med Biol. 1994;356:61-8 - PubMed
27. Clin Chem. 1996 Oct;42(10):1722-3 - PubMed
28. Ann Hematol. 2012 Jun;91(6):905-9 - PubMed
29. East Mediterr Health J. 2007 Jul-Aug;13(4):780-6 - PubMed
30. Haematologica. 2008 Jan;93(1):111-5 - PubMed
31. Eur J Clin Chem Clin Biochem. 1997 Sep;35(9):647-54 - PubMed
32. N Engl J Med. 1999 Feb 11;340(6):448-54 - PubMed

Publication Types

• Journal Article